BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 8274301)

  • 1. European Guidelines for Quality Assurance in Cervical Cancer Screening. Europe against cancer programme.
    Coleman D; Day N; Douglas G; Farmery E; Lynge E; Philip J; Segnan N
    Eur J Cancer; 1993; 29A Suppl 4():S1-38. PubMed ID: 8274301
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality control in cytopathology applied to screening for cervical carcinoma.
    Marsan C
    Pol J Pathol; 1995; 46(4):245-8. PubMed ID: 8713292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Guidelines for the evaluation of internal quality control of smears for screening of uterine cancer in France in the structures of Pathologic Anatomy and Cytology. French Association for Quality Assurance in Pathologic Anatomy and Cytology (AFAQAP)--Commission for cervical smears].
    Albuisson F; Anger E; Baron V; Cartier I; Dorne H; Dubois-Gordeff A; Hassoun J; Jouannelle A; Labbé S; Locquet D; Marsan C; Martin E; Michiels-Marzias D; Molinié V; Mottot C; Mueller B; Vacher-Lavenu MC; Vincent S; Vuong PN
    Ann Pathol; 1998 Jul; 18(3):221-6. PubMed ID: 9750045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance in cervical cytopathology.
    Light AM
    Cytopathology; 1997 Aug; 8(4):290-2. PubMed ID: 9252748
    [No Abstract]   [Full Text] [Related]  

  • 5. [Cervical cancer screening. False negative smears].
    Vassilakos P; De Marval F; Muñoz M
    Rev Med Suisse Romande; 1997 Aug; 117(8):597-601. PubMed ID: 9340714
    [No Abstract]   [Full Text] [Related]  

  • 6. [Re: the editorial in number 4, volume 28, 2008. "Cervical cancer control in Colombia: achievements and challenges of cytology based programs"].
    Calvache AE
    Biomedica; 2009 Mar; 29(1):161-2; author reply 162-3. PubMed ID: 19753849
    [No Abstract]   [Full Text] [Related]  

  • 7. [European guidelines for quality assurance in the screening for cancer of the uterine cervix].
    Lynge E; Philip J
    Ugeskr Laeger; 1994 Mar; 156(11):1654. PubMed ID: 8009664
    [No Abstract]   [Full Text] [Related]  

  • 8. ASC/SIL Ratio for Cytotechnologists: A surrogate marker of screening sensitivity.
    Renshaw AA; Deschênes M; Auger M
    Am J Clin Pathol; 2009 Jun; 131(6):776-81. PubMed ID: 19461082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European guidelines for quality assurance in cervical cancer screening: recommendations for cervical cytology terminology.
    Herbert A; Bergeron C; Wiener H; Schenck U; Klinkhamer P; Bulten J; Arbyn M
    Cytopathology; 2007 Aug; 18(4):213-9. PubMed ID: 17635161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Personnel training for a population screening program for cervical carcinoma].
    Branca M; Rossi E; Cedri C; Migliore G; Cedri S; Aldovini A; Leoncini L; Bonelli L; Montanari G; Navone R
    Pathologica; 2001 Jun; 93(3):233-41. PubMed ID: 11433619
    [No Abstract]   [Full Text] [Related]  

  • 11. [The European aptitude test for cervical cytopathology].
    Branca M
    Pathologica; 2001 Feb; 93(1):28-33. PubMed ID: 11294016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening from the public health perspective.
    Steiner C
    Acta Cytol; 1989; 33(4):471-4. PubMed ID: 2750437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories.
    Wiener HG; Klinkhamer P; Schenck U; Arbyn M; Bulten J; Bergeron C; Herbert A
    Cytopathology; 2007 Apr; 18(2):67-78. PubMed ID: 17397490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a Pap smear quality-assurance system in family practice.
    Curtis P; Varenholt JJ; Skinner B; Addison L; Resnick J; Kebede M
    Fam Med; 1993 Feb; 25(2):135-9. PubMed ID: 8458544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Partial re-screening of all negative smears. A method of quality control of pathology department concerning smear screening against cervix cancer].
    Jensen ML; Dybdahl H; Svanholm H
    Ugeskr Laeger; 2000 May; 162(21):3024-7. PubMed ID: 10850190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of PAPNET--a semiautomated system used in the screening against cervical cancer].
    Hølund B; Ejersbo D; Hjortebjerg A
    Ugeskr Laeger; 1998 Sep; 160(40):5802-6. PubMed ID: 9782761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ASC/SIL ratio for cytotechnologists: A survey of its utility in clinical practice.
    Renshaw AA; Auger M; Birdsong G; Cibas ES; Henry M; Hughes JH; Moriarty A; Tench W; Wilbur DC; Elsheikh TM
    Diagn Cytopathol; 2010 Mar; 38(3):180-3. PubMed ID: 19760762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Report of a national workshop on screening for cancer of the cervix.
    Rasaiah B
    CMAJ; 1992 Apr; 146(8):1279-80; author reply 1280, 1284-5. PubMed ID: 1622496
    [No Abstract]   [Full Text] [Related]  

  • 19. Report of a National Workshop on Screening for Cancer of the Cervix.
    Miller AB; Anderson G; Brisson J; Laidlaw J; Le Pitre N; Malcolmson P; Mirwaldt P; Stuart G; Sullivan W
    CMAJ; 1991 Nov; 145(10):1301-25. PubMed ID: 1933712
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cervical smears taken by physicians' assistants are of lesser quality than smears taken by family physicians, but almost as good as the national average].
    van Rijswijk A
    Ned Tijdschr Geneeskd; 2000 Feb; 144(8):399. PubMed ID: 10703599
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.